Hesitancy to Receive the Booster Doses of COVID-19 Vaccine Among Cancer Patients in China: A Multicenter Cross-Sectional Survey — Four PLADs, China, 2022

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Cancer patients are more vulnerable and have higher mortality rates from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than the general population; however, coverage for booster doses of the coronavirus disease 2019 (COVID-19) vaccine was low am...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuxiao, Zhang, Lei, Chen, Siyu, Lan, Xinquan, Song, Moxi, Su, Rila, Yang, Jianzhou, Wang, Zixin, Xu, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061813/
https://www.ncbi.nlm.nih.gov/pubmed/37006443
http://dx.doi.org/10.46234/ccdcw2023.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061813/
https://www.ncbi.nlm.nih.gov/pubmed/37006443
http://dx.doi.org/10.46234/ccdcw2023.041

Ejemplares similares